查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1548916

药用塑胶包装：市场占有率分析、行业趋势和统计、成长预测（2024-2029）

Pharmaceutical Plastic Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 132 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2024年药品塑胶包装市场规模为521.9亿美元，预计2029年将达693.3亿美元，预测期内（2024-2029年）复合年增长率为5.85%。

药用塑胶包装-市场

主要亮点

  • 由于传染性和非传染性疾病的包装需求，全球药用塑胶包装产业正在快速成长。这种增长主要是由于需要保护药品免受损坏、污染和其他外部因素的影响。随着技术的进步，对瓶子、管瓶和其他包装解决方案和药品的需求不断增加。
  • 此外，对注射剂的需求不断增长是推动塑胶包装产业发展的关键因素。主要成长要素是对抗癌药物、强效药物（如抗体偶联物和速效类固醇）的高需求以及不断增加的药品支出。同时，该行业正在转向更永续的包装解决方案，以确保药品安全，同时减少对环境的影响。
  • 日益严格的法规正在推动业界采用更好的包装解决方案来满足这些新标准。人口老化和慢性病的增加也推动了对药用塑胶包装的需求。
  • 保护药品免受光、湿气、污染和物理损坏极为重要。这种需求凸显了创新包装解决方案的重要性，以确保产品安全并满足严格的法规。包装技术的未来进步预计将提高医药领域硬质塑胶包装的保护性和永续性。
  • 此外，随着世界对医疗保健的兴趣增加，製药公司正在扩张和投资以增加利润。例如，2023 年 3 月，Oliver Healthcare Packaging 宣布在马来西亚开设新製造工厂，扩大在亚太地区的业务。
  • 政府机构越来越多地禁止或限制在药品包装中使用某些类型的塑胶。这些法规通常针对一次性和非回收塑料，并且是出于环境问题的考虑。因此，药品包装的选择变得更加有限，可能会减少对塑胶包装的需求。这些监管变化将透过鼓励使用更环保的替代品（例如生物基、生物分解性和回收材料）来影响市场。

药用塑胶包装市场趋势

药品包装越来越多地采用聚对苯二甲酸乙二醇酯 (PET)

  • 聚对苯二甲酸乙二醇酯 (PET) 是聚酯家族的一员，是一种透明、坚固且安全的塑胶。它无毒、不致癌性，非常适合药品包装。 PET 可以免受二氧化碳和光线的影响，并能排斥微生物。也获得 EU、NSF 和 FDA核准。
  • PET 重量轻，具有玻璃般的外观，使其具有视觉吸引力。它还坚固、不发生反应且防碎，确保了高药物安全标准。 PET 也可回收利用，支援环境永续性。 PET 重量轻、耐用且可回收，是药品包装的最佳选择，可确保药品的安全性和完整性。
  • 多年来，PET 已成为以其安全性和品质而闻名的领先塑料。它广泛用于包装液体内服药物，特别是儿童和老年人。 PET 的独特特性凸显了其在製药领域日益增长的重要性。
  • 包装製造商致力于提供创新的 PET 包装解决方案，以满足製药业对永续塑胶包装不断增长的需求。例如，2024 年 1 月，Bormioli Pharma SpA 与 Loop Industries Inc. 合作，宣布推出一款由 100% 回收原生 PET 树脂製成的创新药品包装瓶。这将使公司能够应对永续实践和材料的日益采用，以减少製药业对环境的影响。
  • 此外，PET 比玻璃轻 90%，降低了运输成本。 PET塑胶瓶取代了製药业中较重的玻璃瓶，并为各种液体产品提供了可重复使用的解决方案。例如，中国塑胶製品产量从2023年10月的656万吨大幅增加至2024年1月/2月的1,189万吨。这一增长主要是由于製药业对塑胶包装的需求增加。

中国和印度的医疗改革推动医药塑胶包装的成长

  • 中国蓬勃发展的医药产业为医药塑胶包装企业提供了许多机会。中国政府正在进行的医疗改革可能会加速该行业的扩张。对药品安全性和合规性的日益关注正在推动对复杂包装解决方案的需求。此外，随着中国人口老化和慢性病的日益流行，药品消费量预计将激增，这将直接增加对药品塑胶包装的需求。
  • 中国医药包装企业正在加大对内部研发团队的投资。该运动旨在探索先进、环保、安全和永续的包装材料和产品。这种策略转变以及技术创新、联盟、收购和药品生产的激增正在推动市场价值。
  • 例如，Saner Group 是医疗保健包装和医疗组件领域的领导者。 2023 年 11 月，该公司在中国昆山推出了最先进的製造工厂，扩大了在亚太地区的业务范围。该厂专用用地面积18,000 平方米和 4,000 平方米，符合 D 级无尘室标准，确保给药装置和医疗包装的生产符合 GMP 要求。
  • 此外，印度的医疗改革，特别是 PLI（生产挂钩激励）制度，对于推动市场成长至关重要。该计划是印度自力更生计划（Atmanirbhar Bharat）的基石，强调促进国内製造业。这些措施使得印度医药塑胶包装市场专注于监管合规和回收。
  • 印度致力于加强医疗保健基础设施和增加对製药业的投资，进一步巩固了市场的成长轨迹。根据印度药品生产商组织的数据，2022 年製药业的价值将达到 490 亿美元。预计到2030年这数字将增加至1,300亿美元，到2047年将增加至4,500亿美元，医药塑胶包装市场前景看好。

药用塑胶包装产业概况

医药塑胶包装市场的竞争格局较为分散，由 Gerresheimer AG、Amcor Group GmbH、Berry Global Inc.、Aptar Group Inc.、Comar LLC 和 West Pharmaceutical Services, Inc. 等公司组成。市场上的公司正致力于扩大产能，以满足製药业对塑胶包装不断增长的需求。

2024 年 4 月 Berry Global Group Inc. 是一家以患者为中心的医疗保健解决方案製造商，透过投资增强的资产和製造能力，增强了其医疗保健生产能力。这项战略倡议将使欧洲三座工厂的产量增加 30%。

2023 年 11 月，领先的包装开发和製造公司 Amcor Group GmbH 宣布其在医用层压材料领域的最新创新。这种先进的包装透过引入无缝融入聚乙烯回收流的全薄膜包装，向前迈出了重要的一步。这种新的包装解决方案是单一材料聚乙烯 (PE) 层压板，旨在满足各种包装需求。可回收的替代品可以无缝地取代不可回收的盖子，特别是在常用于手术单、导管和注射系统的 3D 热成型包装中。这些层压材料也可应用于 2D 袋，非常适合创伤护理材料和手套等产品。

其他好处：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度
  • 产业价值链分析
  • 评估地缘政治情境对产业的影响

第五章市场动态

  • 市场驱动因素
    • 对硬质和软质药用塑胶产品的需求不断增加
    • 发展更好、更先进的医疗基础设施
  • 市场限制因素
    • 限製药用塑胶产品销售和供应的法规
    • 原料成本波动

第六章 市场细分

  • 按原料分
    • 聚丙烯（PP）
    • 聚对苯二甲酸乙二酯 (PET)
    • 低密度聚乙烯（LDPE）
    • 高密度聚苯乙烯（HDPE）
    • 其他原料
  • 依产品类型
    • 固态容器
    • 滴管瓶
    • 滴鼻剂瓶
    • 液体瓶
    • 口腔护理
    • 小袋
    • 管瓶和安瓿
    • 墨水匣
    • 注射器
    • 盖子和塞子
    • 其他产品类型
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 义大利
    • 亚洲
      • 中国
      • 印度
      • 日本
      • 澳洲/纽西兰
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
    • 中东/非洲
      • 阿拉伯聯合大公国
      • 沙乌地阿拉伯
      • 南非

第七章 竞争格局

  • 公司简介
    • Gerresheimer AG
    • Amcor Group GmbH
    • Berry Global Inc.
    • Aptar Group Inc.
    • O.Berk Company LLC
    • Pretium Packaging LLC
    • Klockner Pentaplast Group
    • Comar LLC
    • Gil Pack Group
    • Drug Plastics & Glass Company Inc.
    • West Pharmaceutical Services Inc.

第八章投资分析

第9章市场的未来

简介目录
Product Code: 71382

The Pharmaceutical Plastic Packaging Market size is estimated at USD 52.19 billion in 2024, and is expected to reach USD 69.33 billion by 2029, growing at a CAGR of 5.85% during the forecast period (2024-2029).

Pharmaceutical Plastic Packaging - Market

Key Highlights

  • The global pharmaceutical plastic packaging sector is growing fast because of the need for packaging for both communicable and non-communicable diseases. This growth is mainly due to the need to protect medicines from damage, contamination, and other external factors. As technology advances, the demand for bottles, vials, and other packaging solutions and medicines increases.
  • Additionally, the rising demand for injectables is a crucial factor driving the plastic packaging sector. The main growth drivers are the high demand for cancer drugs, strong medications (like antibody conjugates and fast-acting steroids), and increased drug spending. At the same time, the industry is seeing more sustainable packaging solutions to reduce environmental impact while keeping medicines safe.
  • Stricter regulations push the industry to adopt better packaging solutions that meet these new standards. The aging population and the rise in chronic diseases also increase the demand for pharmaceutical plastic packaging.
  • Protecting medicines from light, moisture, contamination, and physical damage is crucial. This need highlights the importance of innovative packaging solutions that ensure product safety and meet strict regulations. Future advancements in packaging technology are expected to improve the protective and sustainable features of rigid plastic packaging in the pharmaceutical sector.
  • Also, as global healthcare concerns grow, pharmaceutical companies expand and invest to increase profits. For example, in March 2023, Oliver Healthcare Packaging announced the opening of a new manufacturing facility in Malaysia, expanding its presence in Asia-Pacific.
  • Government bodies are increasing bans and restrictions on certain types of plastics used in pharmaceutical packaging. These restrictions, often on single-use and non-recycled plastics, are due to environmental concerns. As a result, the options for pharmaceutical packaging are becoming more limited, which may reduce the demand for plastic packaging. These regulatory changes encourage using more eco-friendly alternatives, like bio-based, biodegradable, or recycled materials, which impact the market.

Pharmaceutical Plastic Packaging Market Trends

Increasing Adoption of Polyethylene Terephthalate (PET) Packaging for Pharmaceutical Products

  • Polyethylene terephthalate (PET), a member of the polyester family, is a clear, strong, and safe plastic. It is non-toxic and non-carcinogenic, making it ideal for pharmaceutical packaging. PET protects against CO2 and light and repels microorganisms. The EU, NSF, and FDA also approve it.
  • PET's lightweight nature and glass-like appearance make it visually appealing. It is also strong, non-reactive, and shatterproof, ensuring high pharmaceutical safety standards. PET is also recyclable, supporting environmental sustainability. Its lightweight, durable, and recyclable combination makes PET a top choice for pharmaceutical packaging, ensuring the safety and integrity of medicines.
  • Over the years, PET has become a leading plastic known for its safety and quality. It is widely used in packaging liquid oral medications, especially for children and the elderly. PET's unique features highlight its growing importance in the pharmaceutical sector.
  • Packaging manufacturers are focusing on offering innovative PET packaging solutions to cater to the growing demand for sustainable plastic packaging in the pharmaceutical sector. For instance, in January 2024, Bormioli Pharma SpA announced the launch of an innovative pharmaceutical packaging bottle made from 100% recycled virgin PET resin along with the partnership of Loop Industries Inc. This will help the company cater to the growing adopting of sustainable practices and materials to reduce its environmental impact in the pharmaceutical sector.
  • Additionally, PET can reduce weight by up to 90% compared to glass, lowering transportation costs. PET plastic bottles replace heavier glass bottles in the pharmaceutical industry, offering a reusable solution for various liquid products. For example, China's plastic product production increased significantly, from 6.56 million metric tons in October 2023 to 11.89 million in January/February 2024. This increase is mainly due to the rising demand for plastic packaging in the pharmaceutical sector.

China and India's Healthcare Reforms Drive Growth in Pharmaceutical Plastic Packaging

  • China's thriving pharmaceutical sector offers numerous opportunities for pharmaceutical plastic packaging companies. The Chinese government's ongoing healthcare reforms are set to amplify this sector's expansion. The demand for sophisticated packaging solutions is rising with a growing emphasis on drug safety and compliance. Moreover, as China's population ages and chronic diseases become more prevalent, the consumption of pharmaceuticals is expected to surge, directly boosting the need for pharmaceutical plastic packaging.
  • Chinese pharmaceutical packaging firms are increasingly investing in in-house R&D teams. This move aims to explore advanced, eco-friendly, secure, and sustainable packaging materials and products. This strategic shift and a surge in innovation, partnerships, acquisitions, and drug production elevate the market's value.
  • For instance, the Sanner Group is a leader in healthcare packaging and medical components. In November 2023, the company expanded its footprint in the Asia-Pacific by launching a state-of-the-art manufacturing plant in Kunshan, China. Covering 18,000 m2, with 4,000 m2 dedicated to production, the facility meets Class D clean room standards, ensuring GMP-compliant manufacturing for drug delivery devices and medical packaging.
  • Also, India's healthcare reforms, notably the Production Linked Incentive (PLI) scheme, are pivotal in driving market growth. This scheme, a cornerstone of India's self-reliance initiative (Atmanirbhar Bharat), underscores the nation's push for local manufacturing. These initiatives drive India's pharmaceutical plastic packaging market with a heightened focus on regulatory compliance and recycling.
  • India's commitment to bolstering healthcare infrastructure and its increased investments in the pharmaceutical sector further solidify the market's growth trajectory. According to the Organisation of Pharmaceutical Producers of India, the pharmaceutical industry was valued at USD 49 billion in 2022. Projections suggest this figure could soar to USD 130 billion by 2030 and an impressive USD 450 billion by 2047, offering a promising outlook for the pharmaceutical plastic packaging market.

Pharmaceutical Plastic Packaging Industry Overview

The competitive landscape of the pharmaceutical plastic packaging market is fragmented, consisting of several players like Gerresheimer AG, Amcor Group GmbH, Berry Global Inc., Aptar Group Inc., Comar LLC, West Pharmaceutical Services, Inc., and more. The players in the market are focusing on expanding their capacities to cater to the growing need for plastic packaging in the pharmaceutical sector.

April 2024: Berry Global Group Inc., a player in manufacturing patient-centric healthcare solutions, bolstered its healthcare production capacity by investing in enhanced assets and manufacturing capabilities. This strategic move is set to amplify production by as much as 30% at three of its European facilities.

November 2023: Amcor Group GmbH, a leading packaging developer and producer, unveiled its latest innovation in Medical Laminates. This advancement marks a significant step forward, introducing all-film packaging that seamlessly fits into the polyethylene recycling stream. The new packaging solution is a mono-material polyethylene (PE) laminate designed to cater to diverse packaging needs. Notably, a recyclable alternative can seamlessly substitute non-recyclable lids in 3D thermoformed packages commonly utilized for drapes, catheters, and injection systems. Also, these laminates find application in 2D pouches, which is ideal for products like wound care materials and gloves.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of Geopolitical Scenario on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products
    • 5.1.2 Development of Better and More Advanced Healthcare Infrastructure
  • 5.2 Market Restraints
    • 5.2.1 Regulations Restricting the Sales and Availability of Pharmaceutical Plastic Products
    • 5.2.2 Fluctuations in Raw Material Cost

6 MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polypropylene (PP)
    • 6.1.2 Polyethylene Terephthalate (PET)
    • 6.1.3 Low Density Polyethylene (LDPE)
    • 6.1.4 High Density Polyethylene (HDPE)
    • 6.1.5 Other Raw Materials
  • 6.2 By Product Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Pouches
    • 6.2.7 Vials and Ampoules
    • 6.2.8 Cartridges
    • 6.2.9 Syringes
    • 6.2.10 Caps and Closures
    • 6.2.11 Other Product Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 France
      • 6.3.2.4 Spain
      • 6.3.2.5 Italy
    • 6.3.3 Asia
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
      • 6.3.3.4 Australia and New Zealand
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Argentina
      • 6.3.4.3 Mexico
    • 6.3.5 Middle East and Africa
      • 6.3.5.1 United Arab Emirates
      • 6.3.5.2 Saudi Arabia
      • 6.3.5.3 South Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Amcor Group GmbH
    • 7.1.3 Berry Global Inc.
    • 7.1.4 Aptar Group Inc.
    • 7.1.5 O.Berk Company LLC
    • 7.1.6 Pretium Packaging LLC
    • 7.1.7 Klockner Pentaplast Group
    • 7.1.8 Comar LLC
    • 7.1.9 Gil Pack Group
    • 7.1.10 Drug Plastics & Glass Company Inc.
    • 7.1.11 West Pharmaceutical Services Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET